Power Law company profile

Capricor Therapeutics

Biotech & Life Sciences · Beverly Hills, United States · Founded 2005 · IPO 2013 Unicorn

Innovative cell and exosome-based therapeutics for disease treatment and prevention

Valuation

$1.64B

Market cap · May/2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

2 investors on Capricor Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 2 investors entered at this stage

Westport Resources Investment Services

Coniston Capital

Global footprint

Where Capricor Therapeutics has talent and traffic

Workforce by country

🇺🇸 United States · Beverly Hills HQ

Book a demo for the full country breakdown

Web traffic by country

22K monthly visits
across markets

🇺🇸 United States66.8%

🇮🇳 India10.5%

🇬🇧 United Kingdom7.7%

🇯🇵 Japan6.8%

🏳️ Korea5%

Top 5 markets shown

Market sentiment

What the market is saying about Capricor Therapeutics

An AI-synthesized read of the highest-engagement posts about Capricor Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Capricor Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles